Novocure Gmbh
Clinical trials sponsored by Novocure Gmbh, explained in plain language.
A medical device company developing tumor-treating electric fields for cancer therapy.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Electric field therapy extends life in advanced lung cancer trial
Disease control CompletedThis phase 3 trial tested a portable device that creates electric fields to disrupt cancer cell division in 291 people with stage 4 non-small cell lung cancer that had worsened after initial chemotherapy. Participants wore the device on their chest while continuing standard treat…
Phase: PHASE3 • Sponsor: NovoCure GmbH • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Electric field device shows promise for lung cancer brain spread
Disease control CompletedThis study tested whether a portable device that creates low-intensity electric fields (called Tumor Treating Fields, or TTFields) can help control brain tumors that have spread from non-small cell lung cancer. 298 adults with 1 to 10 brain metastases received standard radiosurge…
Phase: PHASE3 • Sponsor: NovoCure GmbH • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC